Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Does PackML Hinder the OEM’s Ability to Differentiate?

In a recent discussion on PMMI’s LinkedIn Group, James Laverdiere of KleenLine Corp. opined that it was time for broad industry adoption of PackML, describing it as “a standardized language that delivers great improvements for packaging operations.” Here are the two comments that were posted:

From Richard Kurtz, principal consultant at Ptarmigan Consulting:

I agree the concept is excellent, particularly for new entrants to the field. Costs for well established companies can be prohibitive, plus there is often reluctance as it can diminish the differentiation of one brand from another. Much more discussion is needed and this could be a forum for this.

From Rob Aleksa, recently retired packaging and controls engineer at Procter & Gamble:

Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report